|
Market Closed -
London S.E.
23:35:10 28/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 74.00 GBX | +8.03% |
|
+12.12% | -8.07% |
| 08-14 | EARNINGS AND TRADING: tinybuild sues Max Ent; Light Science loss grows | AN |
| 08-13 | Arecor Therapeutics plc Publishes Clinical Data for AT278 in Peer-Reviewed Journal | CI |
| Market Cap | 27.94M 37.88M 32.64M 30.61M 52.63M 3.62B 52.8M 363M 142M 1.83B 142M 139M 6.06B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 26.62M 36.09M 31.1M 29.16M 50.15M 3.45B 50.31M 346M 135M 1.74B 136M 133M 5.77B | EV / Sales 2026 * |
30.3x | EV / Sales 2027 * | 29.7x |
| Free-Float |
46.91% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Arecor Therapeutics plc
| 1 day | +8.03% | ||
| 1 week | +12.12% | ||
| Current month | +21.31% | ||
| 1 month | +16.54% | ||
| 3 months | +12.12% | ||
| 6 months | +2.07% | ||
| Current year | -8.07% |
| 1 week | 65 |  | 74.5 |
| 1 month | 55.27 | | 74.5 |
| Current year | 55.27 | | 95 |
| 1 year | 55.27 | | 100 |
| 3 years | 35.4 | | 199 |
| 5 years | 35.4 | | 472 |
| 10 years | 35.4 | | 472 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah Howell
CEO | Chief Executive Officer | 51 | 13/04/2021 |
David J. Ellam
DFI | Director of Finance/CFO | - | 18/11/2024 |
Jan Jezek
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Richards
CHM | Chairman | 66 | 13/04/2021 |
David J. Ellam
BRD | Director/Board Member | - | 29/09/2025 |
Sarah Howell
BRD | Director/Board Member | 51 | 13/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/5/26 | Free | Chief Executive Officer | 160,000 | 0.4238% | ||
| 20/5/26 | Free | Executive/Senior Manager | 95,000 | 0.2516% | ||
| 20/5/26 | Free | Chief Financial Officer | 105,000 | 0.2781% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.03% | +12.12% | +16.54% | -61.05% | 37.88M | |
| -1.23% | -1.91% | +0.98% | +17.94% | 50.47B | |
| -2.03% | -3.87% | +414.52% | +498.73% | 44.56B | |
| -1.22% | -1.10% | +40.08% | +15.61% | 43.08B | |
| -2.97% | -3.83% | +7.74% | +72.36% | 41.7B | |
| -0.94% | -1.77% | +18.34% | +46.84% | 33.21B | |
| -1.97% | -5.48% | +23.82% | +116.85% | 16.77B | |
| +5.99% | +3.53% | - | - | 16.28B | |
| +0.25% | -0.98% | +11.63% | +27.62% | 14.58B | |
| -1.48% | -3.82% | +78.09% | +38.85% | 13.92B | |
| Average | +0.26% | +0.10% | +67.97% | +85.97% | 27.46B | |
| Weighted average by Cap. | -1.11% | -1.05% | +88.40% | +121.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 878K 1.19M 1.03M 962K 1.65M 114M 1.66M 11.42M 4.45M 57.47M 4.47M 4.37M 191M | 1.05M 1.42M 1.23M 1.15M 1.98M 136M 1.98M 13.65M 5.32M 68.69M 5.35M 5.23M 228M |
| Net income | - | - |
| Net Debt | -1.32M -1.79M -1.54M -1.45M -2.49M -171M -2.49M -17.15M -6.69M -86.34M -6.72M -6.57M -286M | 3.2M 4.34M 3.74M 3.51M 6.03M 415M 6.05M 41.63M 16.24M 210M 16.31M 15.95M 695M |
Employees
33
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | GBX 74.00 | +8.03% | 75,524 |
| 27/08/26 | GBX 68.50 | +3.79% | 34,553 |
| 26/08/26 | GBX 66.00 | 0.00% | 9,469 |
| 25/08/26 | GBX 66.00 | 0.00% | 2,650 |
| 24/08/26 | GBX 66.00 | 0.00% | 3,797 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7400GBP
Average target price
2.755GBP
Spread / Average Target
+272.30%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AREC Stock
Select your edition
All financial news and data tailored to specific country editions
